Form 4: Axon CTO Sells Shares After RSU Vesting
Insider Transaction Report
Axon Enterprise's CPO & CTO, Jeffrey C. Kunins, disposed of common stock through tax withholdings and sales following restricted stock unit vesting, executed under a Rule 10b5-1 plan.
Summary
- Jeffrey C. Kunins, CPO & CTO of Axon Enterprise, Inc., reported transactions involving common stock.
- On December 1, 2025, 1,167 shares were disposed of at $533.21 to cover tax liability resulting from the vesting of restricted stock units.
- On December 1, 2025, an additional 8,114 shares were disposed of at $533.21 to cover tax liability arising from the vesting of the second tranche of restricted stock units granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which performance conditions were certified on March 24, 2025.
- On December 2, 2025, a total of 1,797 shares were sold across multiple trades at weighted average prices ranging from $537.6794 to $541.472.
- These sales were executed pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025, and consisted of shares issued upon the settlement of vested restricted stock units.
- Following these transactions, Kunins directly owns 83,485 shares and indirectly owns 70,593 shares through an LLC, where he is the sole member.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions (tax withholdings and planned sales) following RSU vesting, which is a neutral event for the company's operational performance and does not indicate a change in fundamental outlook.
Positives
- Vesting of restricted stock units (RSUs) indicates the achievement of performance conditions and compensation for the executive.
- Transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating planned rather than opportunistic selling.
Negatives
- Significant disposition of shares by a key executive (CPO & CTO) totaling 11,078 shares through tax withholdings and sales.
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders may perceive insider selling, even if planned, as a slight negative, but the context of RSU vesting and tax withholding mitigates this perception.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Rule 10b5-1 trading plan adopted. |
| 03/24/2025 | Compensation Committee certified performance conditions for RSU vesting. |
| 12/01/2025 | Date of tax withholding transactions for RSU vesting. |
| 12/02/2025 | Date of stock sales pursuant to Rule 10b5-1 plan. |
| 12/03/2025 | Date of filing. |
Recommendation
holdThis Form 4 reports routine insider transactions, specifically tax withholdings and pre-planned sales of shares following RSU vesting by a key executive. Such transactions, executed under a Rule 10b5-1 plan, are generally not indicative of a change in the company's fundamental outlook or the executive's confidence. Therefore, it does not provide new information to warrant a change in investment recommendation.
Keywords
Axon, AXON, Form 4, insider trading, stock sale, RSU vesting, Jeffrey C. Kunins, CPO, CTO, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.